Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06492733 · ClinicalTrials.gov registry record · NA
FastWire REvascularisation of Extremities, (For LOWer Limbs) - FREEFLOW
A NA study of Chronic Total Occlusion of Artery of the Extremities, sponsored by Versono Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 65
- Enrollment target
- 6
- Study locations
NCT06492733 is a NA study of Chronic Total Occlusion of Artery of the Extremities that is actively recruiting participants, run by Versono Medical. The registered enrollment target is 65 participants. The trial reports 6 study locations across 6 states.
The verdict
NCT06492733, a NA study of Chronic Total Occlusion of Artery of the Extremities, is actively recruiting participants, sponsored by Versono Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
- 6
- Study locations
Study Summary
This study is to assess the safety and efficacy of the FastWire System. It is intended to assess that the FastWire System can facilitate the intra-luminal placement of conventional guidewires or treatment devices beyond peripheral artery chronic total occlusions (CTOs)
Conditions Studied
Interventions
- DEVICE FastWire System - Peripheral
Study Locations (6)
Delaware
- EndoVascular Consultants - Wilmington
Florida
- Vascular & Embolization Specialists - Cocoa
Iowa
- Vascular Institute of the Midwest - Davenport
Louisiana
- Cardiovascular Institute of the South-ASC - Gray
Michigan
- Dearborn Cardiology - Dearborn
Tennessee
- Vascular Institute of Chattanooga - Chattanooga
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2024-11-05 |
| Est. Completion | 2026-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06492733
The ClinicalTrials.gov registry entry for NCT06492733 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Versono Medical, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Total Occlusion of Artery of the Extremities appearing as the primary indexed condition, and to 1 intervention - of which FastWire System - Peripheral is the first listed.
NCT06492733 reports 6 study locations spanning 6 distinct geographic areas - top geographies include Delaware, Florida, Iowa.
Frequently Asked Questions
What is clinical trial NCT06492733 about?
NCT06492733 is a clinical study titled "FastWire REvascularisation of Extremities, (For LOWer Limbs) - FREEFLOW". This study is to assess the safety and efficacy of the FastWire System. It is intended to assess that the FastWire System can facilitate the intra-luminal placement of conventional guidewires or treatment devices beyond peripheral artery chronic total occlusions (CTOs)
What is the current status of trial NCT06492733?
This trial is currently recruiting. It is a NA study. The enrollment target is 65 participants. The study started on 2024-11-05. Estimated completion is 2026-07.
What conditions does trial NCT06492733 study?
This clinical trial studies the following conditions: Chronic Total Occlusion of Artery of the Extremities.
What interventions are being tested in trial NCT06492733?
The interventions under investigation include: FastWire System - Peripheral (DEVICE).
Who is sponsoring clinical trial NCT06492733?
This trial is sponsored by Versono Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06492733 being conducted?
This trial has 6 study locations across Delaware, Florida, Iowa, Louisiana, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Total Occlusion of Artery of the Extremities
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.